Juvinor P 75mg/10mg Tablet
Marketer
Biophar Lifesciences Pvt Ltd
Salt Composition
Pregabalin (75mg) + Nortriptyline (10mg)
Overview Juvinor P 75mg/10mg Tablet
Neuropain-75/10 is a dual-action analgesic used to manage neuropathic pain. It reduces pain sensation by interrupting the transmission of pain signals to the central nervous system. Neuropain-75/10 tablets are administered orally, with or without food, ideally before sleep. Consistent daily timing helps ensure stable blood levels. Follow your physician's prescribed dosage and duration; this medication can be habit-forming. If a dose is missed, take it immediately upon recall. Complete the entire course of treatment, even with symptom improvement. Abrupt cessation should be discussed with your doctor. Common adverse effects include constipation, urinary difficulty, weight increase, fatigue, and dry mouth. Dizziness and somnolence may also occur, so avoid activities requiring alertness until the medication's effects are known. Weight gain is possible; regular exercise and a balanced diet can help mitigate this. Report any unusual mood or behavioral shifts, new or worsening depression, or suicidal ideation to your doctor. Prior to commencing treatment, disclose any kidney or liver conditions, and list all other medications being taken, as interactions can impact efficacy or mechanism. Inform your doctor if you are pregnant, intend to become pregnant, or are breastfeeding.
Primary Ingredients of Juvinor P 75mg/10mg Tablet
No text provided. Please provide the text you want me to rephrase.
Uses of Juvinor P 75mg/10mg Tablet
Managing neuropathic pain
Major Benefits of Juvinor P 75mg/10mg Tablet:
Consume this medication precisely as prescribed by your physician, adhering to both the dosage and treatment length. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Juvinor P 75mg/10mg Tablets can be administered with or without food, however, consistent timing is recommended.
Common Side effects of Juvinor P 75mg/10mg Tablet:
- Dryness in mouth
- Increased heart rate
- Sleepiness
- Dizziness
- Tiredness
- Weight gain
- Blurred vision
- Orthostatic hypotension (sudden lowering of blood pressure on standing)
- Uncoordinated body movements
- Increased appetite
- Increased libido
- Paresthesia (tingling or pricking sensation)
- Vertigo
- Vomiting
- Nausea
- Erectile dysfunction
- Joint pain
- Constipation
- Difficulty in urination
How to use Juvinor P 75mg/10mg Tablet:
Administer this medication precisely as your physician directs, adhering to both the prescribed dosage and duration. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Juvinor P 75mg/10mg Tablets can be consumed with or without food, though consistent timing is recommended.
How Juvinor P 75mg/10mg Tablet works:
Juvinor P 75mg/10mg tablets contain pregabalin and nortriptyline, working synergistically to alleviate neuropathic pain. Pregabalin, an alpha-2-delta ligand, reduces pain perception by influencing nerve cell calcium channel function. Nortriptyline, a tricyclic antidepressant, elevates serotonin and noradrenaline levels, thereby inhibiting pain signal transmission within the central nervous system. This combined action provides effective relief from nerve damage-related pain.
SAFETY ADVICE
AlcoholUNSAFE
Concurrent use of Juvinor P 75mg/10mg tablets and alcohol may result in significant sleepiness.
PregnancyCONSULT YOUR DOCTOR
The use of Juvinor P 75mg/10mg Tablet during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to any prescription. Seek medical advice before taking this medication.
Breast feedingCONSULT YOUR DOCTOR
The use of Juvinor P 75mg/10mg tablets while breastfeeding is likely inadvisable. Available human data indicate a potential for the medication to transfer to breast milk, posing a risk to the infant.
DrivingUNSAFE
Driving ability may be impaired by Juvinor P 75mg/10mg Tablets, due to potential side effects that can reduce alertness.
KidneyCAUTION
Patients with kidney impairment should exercise caution when using Juvinor P 75mg/10mg tablets. Dosage modification for Juvinor P 75mg/10mg tablets may be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Juvinor P 75mg/10mg tablets in patients with liver impairment is likely safe. Preliminary findings indicate dose modification may be unnecessary, however, medical advice is recommended.
What if you forget to take Juvinor P 75mg/10mg Tablet :
Should you forget a Juvinor P 75mg/10mg Tablet dose, administer it promptly. Nevertheless, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Juvinor P 75mg/10mg Tablet
| Label | Value |
|---|---|
| Potential for Dependence | None. |
| Type of Treatment | Nervous system |
FAQs on Juvinor P 75mg/10mg Tablet
A combination of Pregabalin 75mg and Nortriptyline 10mg, Juvinor P Tablet is indicated for neuropathic pain management. Its mechanism involves central nervous system action, modulating the activity of overly sensitive or injured nerves to reduce pain perception.
Discontinuing Juvinor P 75mg/10mg Tablet prematurely, even with pain relief, is inadvisable. Follow your physician's prescribed regimen. Abrupt cessation may trigger withdrawal effects including anxiety, insomnia, nausea, pain recurrence, and diaphoresis. A gradual dose reduction is recommended prior to complete discontinuation.
Taking Juvinor P 75mg/10mg Tablets may increase appetite, potentially leading to weight gain. Preventing weight gain is simpler than losing it. Maintain a balanced diet without enlarging portions. Limit high-calorie foods like sugary drinks, fried foods, processed snacks, and desserts. Between meals, choose fruits, vegetables, and low-calorie options instead of junk food. Regular physical activity helps prevent weight gain. Consistent healthy eating and exercise may avoid weight increase.
Taking Juvinor P 75mg/10mg Tablets may cause drowsiness or sudden sleep onset during the day. This may occur without prior warning signs. Refrain from driving, operating equipment, working at heights, or engaging in hazardous activities initially, until the medication's effects are known. Report any such incidents to your physician.
Taking Juvinor P 75mg/10mg tablets may impact sexual function in both males and females. Reported side effects include reduced libido, erectile dysfunction (difficulty achieving or sustaining an erection), and anorgasmia (inability to achieve orgasm). Decreased sexual satisfaction and discomfort during intercourse are also possible. Consult your physician if these issues arise, but do not discontinue Juvinor P 75mg/10mg tablets without medical advice.
Adverse reactions to Juvinor P 75mg/10mg Tablet are infrequent and seldom severe. Seek immediate medical advice if you experience: altered body temperature, respiratory distress, rapid heart rate, fatigue, gait instability, impaired coordination or delayed reflexes, atypical mood or behavioral shifts (including agitation, anxiety, or euphoria), depressive symptoms, hallucinations, delusional thinking, visual disturbances (blurred or double vision), involuntary eye movements, vision impairment, or indications of recurrent infections like pyrexia, rigors, pharyngitis, or oral ulcers. While unusual, these reactions may be serious and require prompt medical intervention.
Patients may experience initial improvements with Juvinor P 75mg/10mg tablets within two weeks, although complete therapeutic effects might not become apparent for two to three months. In some cases, a longer treatment duration may be necessary.
Should you miss a scheduled dose of Juvinor P 75mg/10mg Tablet, and your next dose is imminent, omit the missed dose and continue with your regular schedule. If your next dose is not soon, take the missed dose immediately upon remembering, then resume your normal medication regimen. Avoid doubling up on doses to compensate for a missed one, as this might lead to heightened adverse effects from an overdose. For any uncertainty regarding missed doses, seek advice from your physician.
If this occurs, promptly contact your physician or proceed to the closest emergency room. This is crucial even in the absence of noticeable symptoms or suspected poisoning. Immediate medical care may be necessary. Overdose symptoms can manifest as lethargy, debility, gait instability, diplopia, dysarthria, diarrhea, disorientation, blurred vision, vertigo, fluctuating body temperature, respiratory distress, and tachycardia.
Increasing your medication dosage beyond the prescribed amount won't necessarily improve its effectiveness; instead, it could heighten the risk of severe adverse reactions and potential poisoning. Should your symptoms worsen despite adhering to the recommended dosage, seek medical advice for reassessment.
Taking Juvinor P 75mg/10mg tablets may reduce alertness and impair cognitive function. Avoid driving or operating machinery until you know how this medication affects you. Alcohol consumption should be avoided during treatment as it may intensify the drug's effects. Grapefruit and its juice can interact negatively, potentially resulting in adverse reactions. Increased sun sensitivity is a potential side effect; therefore, minimize sun exposure, wear protective clothing, and apply sunscreen when outdoors during daylight hours.
Routine check-ups with your physician may be necessary after commencing treatment with Juvinor P 75mg/10mg Tablets. Consult your doctor immediately if your symptoms persist or worsen despite adhering to the prescribed dosage, or if you encounter adverse effects that interfere with your daily life.
Retain the tablets in their original packaging until needed. Maintain storage in a cool, dry location. Keep them safely out of children's view and access. Proper disposal of leftover medication is crucial to prevent accidental ingestion by children, pets, or others.
Each Juvinor P 75mg/10mg tablet contains pregabalin and nortriptyline, working together to manage neuropathic pain. The medication soothes hyperactive or injured nerves through central nervous system action, thus reducing pain perception.
Discontinuing Juvinor P 75mg/10mg Tablet, even with pain relief, is inadvisable. Follow your physician's prescribed dosage regimen. Abrupt cessation may trigger withdrawal effects including anxiety, insomnia, nausea, pain recurrence, and diaphoresis. A gradual dose reduction is recommended prior to complete discontinuation.
Taking Juvinor P 75mg/10mg tablets may increase appetite, potentially leading to weight gain. Weight maintenance is simpler than weight loss. Maintain a nutritious, balanced diet without enlarging meal portions. Avoid high-calorie foods like soda, fried foods, potato chips, pastries, cookies, and candy. Between meals, opt for fruits, vegetables, and low-calorie snacks instead of junk food. Regular physical activity will help prevent weight gain. Consistent healthy eating and regular exercise may prevent any weight increase.
Driving, operating machinery, or engaging in hazardous activities should be avoided while taking Juvinor P 75mg/10mg Tablets, especially initially, due to the potential for drowsiness or sudden sleep onset. This medication may cause unexpected sleepiness without warning signs. Report any instances of drowsiness or sudden sleep episodes to your physician.
Taking Juvinor P 75mg/10mg tablets may impact sexual function in both sexes. Reduced libido, erectile dysfunction (difficulty achieving or sustaining an erection), and anorgasmia are frequently reported. Decreased sexual satisfaction and discomfort during intercourse are also possible side effects. Report any such issues to your physician; however, do not discontinue Juvinor P 75mg/10mg tablets without medical consultation.
Adverse reactions to Juvinor P 75mg/10mg tablets are infrequent. Seek immediate medical advice should you experience: altered body temperature, respiratory distress, rapid heartbeat, fatigue, gait instability, impaired coordination or slowed reflexes, atypical mood or behavior (including agitation, anxiety, or elation), depressive symptoms, hallucinations, delusional thinking, visual disturbances (blurred or double vision), involuntary eye movements, vision impairment, or indicators of recurrent infections like fever, intense chills, pharyngitis, or oral ulcers. While uncommon, these reactions warrant prompt medical intervention.
Patients may experience initial improvements with Juvinor P 75mg/10mg tablets within two weeks. Complete therapeutic effects, however, typically manifest within two to three months, though a longer timeframe may be needed for some individuals.
Should you miss a scheduled dose of Juvinor P 75mg/10mg Tablet, and your next dose is imminent, omit the missed dose and proceed with your regular dosing schedule. If your next dose is not soon, take the missed dose immediately upon remembering, then resume your usual medication regimen. Never double the dose to compensate for a missed one; this could heighten the likelihood of adverse reactions from exceeding the prescribed amount. For any uncertainty regarding missed doses, seek guidance from your physician.
If this occurs, promptly contact your physician or proceed to the closest emergency room for assessment. This is crucial regardless of the presence of any symptoms. Immediate medical care may be necessary. Overdose symptoms can manifest as lethargy, debility, gait instability, diplopia, dysarthria, or diarrhea; cognitive impairment, blurred vision, vertigo, fluctuating body temperature, respiratory distress, and tachycardia may also be present.
Increasing the prescribed dosage won't necessarily improve results; instead, it heightens the risk of severe adverse reactions and potential poisoning. Should your symptoms worsen despite adhering to the recommended dosage, seek medical advice for reassessment.
Taking Juvinor P 75mg/10mg tablets may reduce alertness and impair cognitive function. Exercise caution when operating machinery or engaging in activities demanding concentration. Alcohol consumption should be avoided while using Juvinor P 75mg/10mg tablets, as it can potentiate the drug's effects, leading to harmful consequences. Grapefruit and its juice may interact adversely with this medication; therefore, their consumption should be avoided. Increased sun sensitivity is a potential side effect; minimize sun exposure and utilize protective measures like sunscreen and appropriate clothing when outdoors.
Regular check-ups with your physician may be necessary following initiation of Juvinor P 75mg/10mg Tablet therapy. Consult your doctor immediately if your symptoms don't improve with the prescribed dosage, or if you develop bothersome side effects impacting your daily life.
Retain the tablets in their original packaging until needed. Store in a cool, dry location, inaccessible to children. Proper disposal of any leftover medication is crucial to prevent accidental ingestion by children, pets, or others.
A tablet combining 75mg Pregabalin and 10mg Nortriptyline, known as Juvinor P, treats neuropathic pain. It soothes irritated or hyperactive nerves through central nervous system action, reducing pain perception.
Discontinuing Juvinor P 75mg/10mg Tablet, even with pain relief, is inadvisable. Follow your physician's prescribed regimen. Abrupt cessation may trigger withdrawal effects including anxiety, insomnia, nausea, discomfort, and diaphoresis. A gradual dose reduction is recommended prior to complete discontinuation.
Juvinor P 75mg/10mg Tablets may increase appetite, potentially leading to weight gain. Weight maintenance is simpler than weight loss. Maintain a balanced diet without enlarging portion sizes. Avoid calorie-dense foods like sugary drinks, fried foods, processed snacks, and confectionery. Between meals, opt for fruits, vegetables, and low-calorie alternatives instead of junk food. Regular physical activity helps prevent weight gain. Consistent healthy eating and exercise may preclude weight increase.
Taking Juvinor P 75mg/10mg Tablets can cause drowsiness or sudden sleep onset during the day. This may occur without prior warning signs. Refrain from driving, operating equipment, working at heights, or engaging in hazardous activities initially, until you understand the medication's effects on you. Report any such incidents to your physician.
Juvinor P 75mg/10mg Tablets may impact sexual function in both genders. Reported side effects include reduced libido, erectile difficulties (inability to achieve or sustain an erection), and anorgasmia. Decreased sexual satisfaction and discomfort during intercourse may also occur. Consult your physician if you experience these issues; however, do not discontinue Juvinor P 75mg/10mg Tablet use without medical advice.
Adverse reactions to Juvinor P 75mg/10mg Tablet are infrequent. Seek immediate medical advice should you experience: altered body temperature, respiratory distress, rapid heartbeat, fatigue, gait instability, impaired coordination or slowed reflexes, unusual shifts in mood or demeanor (including agitation, anxiety, or elation), depressive symptoms, hallucinations, disordered thought processes, visual disturbances (blurred or double vision), involuntary eye movements, visual impairment, or indicators of recurrent infections like pyrexia, rigors, pharyngitis, or oral ulcers. While uncommon, these reactions warrant prompt medical intervention.
Observable improvements from Juvinor P 75mg/10mg Tablet may begin within two weeks of starting the course. Complete therapeutic effects, however, usually require two to three months. For some individuals, a longer treatment duration might be necessary.
Should you miss a scheduled dose of Juvinor P 75mg/10mg Tablet, and your next dose is imminent, omit the missed dose and continue with your regular schedule. If your next dose is not soon, take the missed dose immediately upon remembering, then resume your usual medication regimen. Avoid doubling up on doses to compensate for a missed one; this could heighten the risk of adverse reactions from an overdose. For any uncertainty regarding missed doses, seek guidance from your physician.
If this occurs, promptly contact your physician or proceed to the closest emergency room. Seek medical assistance regardless of the presence or absence of symptoms. Immediate medical care may be necessary. Overdose symptoms can manifest as lethargy, debility, gait instability, diplopia, dysarthria, diarrhea, disorientation, blurred vision, vertigo, fluctuating body temperature, respiratory distress, and tachycardia.
Increasing the prescribed dosage won't necessarily improve outcomes; instead, it could heighten the risk of severe adverse reactions and harmful effects. Should your symptoms worsen despite adhering to the recommended dosage, seek medical advice for reassessment.
Taking Juvinor P 75mg/10mg Tablets might affect cognitive function and reflexes. Exercise caution when driving or engaging in activities demanding alertness. Alcohol consumption should be avoided during treatment with Juvinor P 75mg/10mg Tablets as it can intensify the medication's effects, posing a risk. Grapefruit and its juice can interact negatively with this medication, potentially leading to adverse reactions. Limit sun exposure and avoid tanning beds, as Juvinor P 75mg/10mg Tablets increase sun sensitivity, raising the risk of sunburn. Protective clothing and sunscreen are recommended during daytime outdoor activities.
Routine check-ups with your physician may be necessary after commencing treatment with Juvinor P 75mg/10mg Tablets. Consult your doctor immediately if your symptoms persist or worsen despite adhering to the prescribed dosage, or if you experience adverse reactions impacting your daily life.
Retain the medication within its original packaging until needed. Maintain storage in a cool, dry location. Keep the medication out of the reach and view of children. Dispose of any leftover medicine using appropriate methods to prevent accidental ingestion by children, pets, or others.
3,018 People bought this recently
Juvinor P 75mg/10mg Table...
103
MRP 125
17% off